Stockreport

FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Epinephrine Nasal Spray as Investigational Treatment for Anaphylaxis

INSYS THERAPEUTICS  (INSY) 
Last insys therapeutics earnings: 11/5 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.insysrx.com
PDF PHOENIX, Aug. 30, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical ca [Read more]